Widespread Repression of Gene Expression in Cancer by a Wnt/β-Catenin/MAPK Pathway

Aberrant Wnt signaling drives a number of cancers through regulation of diverse downstream pathways. Wnt/beta-catenin signaling achieves this in part by increasing the expression of protooncogenes such as MYC and cyclins. However, global assessment of the Wnt-regulated transcriptome in vivo in genetically distinct cancers demonstrates that Wnt signaling suppresses the expression of as many genes as it activates. In this study, we examined the set of genes that are upregulated upon inhibition of Wnt signaling in Wnt-addicted pancreatic and colorectal cancer models. Decreasing Wnt signaling led to a marked increase in gene expression by activating ERK and JNK; these changes in gene expression could be mitigated in part by concurrent inhibition of MEK. These findings demonstrate that increased Wnt signaling in cancer represses MAPK activity, preventing RAS-mediated senescence while allowing cancer cells to proliferate. These results shift the paradigm from Wnt/beta-catenin primarily as an activator of transcription to a more nuanced view where Wnt/beta-catenin signaling drives both widespread gene repression and activation. Significance: These findings show that Wnt/beta-catenin signaling causes widespread gene repression via inhibition of MAPK signaling, thus fine tuning the RAS-MAPK pathway to optimize proliferation in cancer.

Automated summary

Aberrant Wnt signaling in cancer drives both widespread gene repression and activation, promoting cancer cell proliferation. Inhibiting Wnt signaling leads to increased gene expression through activation of the ERK and JNK pathways.